Unleashing Innovative Wound Care Solutions
BioSpectrum Asia|BioSpectrum Asia Sep 2024
The incidence of wounds is rising, especially in the Asia-Pacific (APAC) region. In Australia alone, 420,000 individuals are impacted by chronic wounds, leading to direct healthcare costs of AUD $3 billion, representing 2 per cent of the country's total healthcare expenditure. Similarly, data from Singapore between 2000 and 2017 revealed that the incidence of wounds among hospitalised adults was 300 per 100,000 for those over 18 and 800 per 100,000 for those over 50. Let's explore further.
Ayesha Siddiqui
Unleashing Innovative Wound Care Solutions

In March 2024 the Albanese Government announced over $3 million fund for new initiatives to tackle the hidden epidemic of chronic wounds in Australia. It is estimated that approximately 450,000 Australians currently live with a chronic wound.

Wounds Australia and the Australian College of Nursing (ACN) will receive grants to enhance wound care education and awareness. Wounds Australia will use $2 million to launch a national campaign focused on chronic wound prevention and treatment, aiming to improve public awareness and patient knowledge. ACN will receive $1.073 million to fund scholarships for nurses and Aboriginal Health Workers, enhancing wound management in primary care settings.

In Singapore, the Wound Care Innovation for the Tropics (WCIT) program represents a pioneering research initiative focused on wound care in tropical climates. This programme aims to transform chronic wound care, improve health outcomes, and reduce economic burdens in the region.

Advancements in wound care

Recent breakthroughs in smart bandages, hydrogels, and tissue regeneration are setting the stage for a new era in chronic wound treatment. Chronic wounds, such as diabetic ulcers, surgical wounds, and pressure injuries, present significant health risks. These wounds are susceptible to infections, have prolonged healing times, and can result in serious complications like sepsis or amputation. Globally, around 2 per cent of people are affected by these conditions.

هذه القصة مأخوذة من طبعة BioSpectrum Asia Sep 2024 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة BioSpectrum Asia Sep 2024 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من BIOSPECTRUM ASIA مشاهدة الكل
How To Control Indian Diabetes Growth
BioSpectrum Asia

How To Control Indian Diabetes Growth

World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.

time-read
4 mins  |
December 2024
HIV Prevention Remains Elusive
BioSpectrum Asia

HIV Prevention Remains Elusive

On December 1, the world gathers every year to commemorate World AIDS Day, which serves as an important reminder that we must remain steadfast in our commitment to prevent new HIV (Human Immunodeficiency Virus) infections and provide essential services to all people living with HIV globally. In 2024, the 37th World AIDS Day opens with the theme, \"Collective Action: Sustain and Accelerate HIV Progress.\"

time-read
2 mins  |
December 2024
Karnataka launches India's first GCC policy
BioSpectrum Asia

Karnataka launches India's first GCC policy

Bengaluru Tech Summit 2024

time-read
8 mins  |
December 2024
Innovations in Urological Imaging: Transforming Patient Care in India
BioSpectrum Asia

Innovations in Urological Imaging: Transforming Patient Care in India

Despite advancements in urological imaging, challenges persist in India, particularly regarding cost and accessibility. Government initiatives and public-private partnerships should expand access to imaging facilities. Continued research investment is crucial for developing cost-effective solutions.

time-read
5 mins  |
December 2024
How strategic angel investment is driving global expansion in medtech and diagnostics
BioSpectrum Asia

How strategic angel investment is driving global expansion in medtech and diagnostics

India has firmly established itself as a key player in the global medtech and diagnostics sectors. With a burgeoning healthcare ecosystem and a growing focus on innovation, the country offers a fertile ground for startups looking to scale their solutions both domestically and internationally. Central to this growth is the role of strategic angel investment, which not only provides financial backing but also offers critical mentorship and strategic direction to help these companies expand their reach.

time-read
4 mins  |
December 2024
What's dampening the GLOBAL AMR BATTLE?
BioSpectrum Asia

What's dampening the GLOBAL AMR BATTLE?

Although there have been significant national and worldwide efforts to provide financial incentives for antibiotic research and development, it is still unclear how best to fortify the existing programmes to further spur antibiotic innovation. The incentive programmes in place now are a crucial first step in enhancing the economic viability of antibiotic development. However, it seems like there isn't enough global coordination among all the programmes, which could lead to duplication of effort, funding gaps in the value chain, and the failure to include crucial AMR objectives. Let's dig deeper.

time-read
9 mins  |
December 2024
Indian Lifesciences Industry Going Ahead in its Innovation Journey While Navigating Challenges
BioSpectrum Asia

Indian Lifesciences Industry Going Ahead in its Innovation Journey While Navigating Challenges

While India is a hub for biosimilar manufacturing and continues to build its capabilities to manufacture these complex therapeutics, Indian biopharma companies are building R&D capabilities and establishing public-private collaborations and Centre of Excellences (CoEs) to develop innovative biologics and advanced therapeutic modalities like cell and gene therapy (CGT) and mRNA vaccines and therapies, biopharma sector remained robust in 2023, accounting for $53.8 billion (35 per cent of the BioEconomy). The growth was primarily driven by advances in biotechnology, personalised medicine innovations, and an expanding market for biosimilars in 2024.

time-read
5 mins  |
December 2024
BioPharma's Transformative & Strategic OUTLOOK 2025
BioSpectrum Asia

BioPharma's Transformative & Strategic OUTLOOK 2025

The Indian biopharma industry witnessed notable transformative developments and announcements, marked by innovation, regulatory advancements, and market expansion this year. From achieving global recognition in biosimilars to advancing biomanufacturing capabilities and precision therapeutics, the sector has solidified its role as a key player in the global pharmaceutical landscape. This progress underscores India's strategic focus on leveraging its robust infrastructure, skilled talent pool, and government support to meet the evolving demands of the healthcare industry.

time-read
10+ mins  |
December 2024
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
BioSpectrum Asia

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
BioSpectrum Asia

Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

time-read
1 min  |
BioSpectrum Asia Nov 2024